| Literature DB >> 32232606 |
Mohamed Salem1, Christine Friedrich2, Alexander Thiem2, Mostafa Ahmed Salem2, Thomas Puehler2, Rene Rusch2, Rouven Berndt2, Jochen Cremer2, Assad Haneya2.
Abstract
BACKGROUND: Various studies evaluated the relationship between hypothermic circulatory arrest and neurological outcome in patients undergoing replacement of ascending aorta. The current analysis focuses on the effect of moderate hypothermic circulatory arrest (MHCA) on elderly patients. The aim of our study was to evaluate the impact of MHCA on neurological outcomes in elderly patients undergoing replacement of the ascending aorta.Entities:
Keywords: Ascending aorta; Hypothermic circulatory arrest; Stroke in cardiac patient
Year: 2020 PMID: 32232606 PMCID: PMC7105549 DOI: 10.1186/s43044-020-00043-7
Source DB: PubMed Journal: Egypt Heart J ISSN: 1110-2608
Fig. 1Consort diagram of the total population with exclusion
Demographic data, preoperative risk factors
| Total | Young group | Elderly group | ||
|---|---|---|---|---|
| Mean age, years | 66.7 ± 11.1 69.2 (61.0, 74.4) | 63.2 ± 10.2 66.3 (57.5, 70.9) | 78.7 ± 3.0 78.0 (76.3, 80.1) | |
| Female gender, | 301 (33.3%) | 221 (31.5%) | 80 (39.4%) | |
| Body mass index, kg/m2 | 26.5 (24.2, 29.4) | 26.8 (24.2, 29.7) | 25.4 (23.7, 27.8) | |
| EuroSCORE II% | 4.12 (2.38, 7.13) | 11.6% (7.4, 19.9) | 26.7% (18.1, 36.3) | |
| Ejection fraction, % | 64 (53, 70) | 62 (51, 70) | 65 (55, 70) | 0 |
| Aortic aneurysm, | 823 (90.9%) | 647 (92.2%) | 176 (86.7%) | |
| Diameter of aneurysm, mm | 52 (50, 57) | 52 (50, 56) | 52 (49, 59) | 0.574 |
| Aortic calcification, | 113 (12.5%) | 55 (7.8%) | 27 (13.3%) | 0.017 |
| Acute myocardial infarction, | 10 (1.1%) | 8 (1.1%) | 2 (1.0%) | 1.000 |
| Diabetes mellitus type II, | 108 (11.9%) | 75 (10.7%) | 33 (16.3%) | |
| Peripheral vascular disease, | 108 (11.9%) | 34 (4.8%) | 17 (8.4%) | 0.055 |
| Arterial hypertension, | 687 (75.9%) | 523 (74.5%) | 164 (80.8%) | 0.065 |
| Atrial fibrillation, | 163 (18.0%) | 115 (16.4%) | 48 (23.6%) | |
| Chronic obstructive pulmonary disease, | 104 (11.5%) | 74 (10.6%) | 30 (14.8%) | 0.097 |
| Coronary heart disease, | 350 (38.8%) | 249 (35.6%) | 101 (49.8%) | |
| Chronic renal failure, | 99 (11.0%) | 64 (9.1%) | 35 (17.2%) | |
| Renal replacement therapy, | 10 (1.1%) | 8 (1.1%) | 2 (1.0%) |
Intraoperative course
| Total | Young group | Elderly group | ||
|---|---|---|---|---|
| Surgical procedure | ||||
| Interposition graft alone, | 508 (56.1%) | 380 (51.1%) | 128 (63.1%) | 0.024 |
| Interposition graft with partial arch replacement, | 203 (22.4%) | 159 (22.6%) | 44 (21.7%) | 0.769 |
| Interposition graft with total arch replacement, | 29 (3.2%) | 21 (3.0%) | 8 (3.9%) | 0.501 |
| Interposition graft with separated aortic valve replacement, | 462 (51.0%) | 356 (50.7%) | 106 (52.2%) | 0.706 |
| Composite graft replacement of aortic root with reimplantation of coronary arteries, | 149 (16.5%) | 124 (17.7%) | 25 (12.3%) | 0.070 |
| Valve sparing aortic root replacement, | 63 (7.0%) | 56 (8.0%) | 7 (3.4%) | |
| Performed CABG, | 222 (24.6%) | 164 (23.4%) | 58 (28.6%) | 0.131 |
| Length of surgery, min | 250 (203, 308) | 252 (205, 313) | 240 (200, 294) | 0.187 |
| Cardiopulmonary bypass time, min | 142 (113, 187) | 144 (113, 189) | 139 (110, 183) | 0.225 |
| Cross-clamp time, min | 92 (65, 125) | 92 (65, 127) | 91 (63, 116) | 0.348 |
| Circulatory arrest, min | 14 (12, 18) | 14 (12, 17) | 15 (12, 18) | 0.419 |
| Temperature, °C | 24 ± 2 | 24 ± 2 | 24 ± 2 | 1.0 |
| Number of packed red blood cells, units | 2 (0, 4) | 2 (0, 4) | 2 (1, 4) | |
| Number of platelets concentrate, units | 1 (0, 1) | 1 (0, 2) | 1 (0, 1) | 0.753 |
| Arterial cannulation, | ||||
| Ascending aorta | 680 (80.2%) | 520 (78.7%) | 160 (85.6%) | |
| Aortic arch | 107 (12.6%) | 93 (14.1%) | 14 (7.5%) | |
| Transatrial through the left ventricle | 48 (5.7%) | 36 (5.4%) | 12 (6.4%) | |
| Femoral artery | 10 (1.2%) | 9 (1.4%) | 1 (0.5%) | |
Postoperative data and outcomes
| Total | Young group | Elderly group | ||
|---|---|---|---|---|
| Postoperative status | ||||
| Stable | 325 (36.0%) | 258 (36.8%) | 67 (33.3%) | |
| Stable with low-dose catecholamines | 533 (59.1%) | 411 (58.6%) | 122 (60.7%) | |
| Stable with high-dose catecholamines | 33 (3.7%) | 22 (3.1%) | 11 (5.5%) | |
| IABP/ECLS with catecholamines | 10 (1.1%) | 9 (1.3%) | 1 (0.5%) | |
| 48-h drainage loss, mL | 600 (400, 950) | 550 (358, 900) | 600 (400, 1150) | |
| Re-exploration for bleeding, | 59 (6.5%) | 51 (7.3%) | 8 (3.9%) | 0.090 |
| Ventilation time, h | 17 (12 31) | 17 (11, 26) | 20 (15, 57) | |
| Tracheotomy, | 69 (7.6%) | 50 (7.1%) | 19 (9.4%) | 0.293 |
| Pulmonary infection | 58 (6.4%) | 37 (5.3%) | 21 (10.3%) | |
| New onset of hemodialysis, | 48 (5.3%) | 36 (5.1%) | 12 (5.9%) | 0.667 |
| Postoperative atrial fibrillation, | 140 (15.7%) | 95 (13.7%) | 45 (22.6%) | |
| Postoperative delirium, | 112 (12.4%) | 63 (9.0%) | 49 (24.1%) | |
| Postoperative stroke (CT-proofed), | 52 (5.7%) | 42 (6.0%) | 10 (4.9%) | 0.569 |
| Deep sternal wound infection, | 12 (1.3%) | 6 (0.9%) | 6 (3.0%) | |
| Intensive care unit stay, days | 2 (1, 4) | 2 (1, 3) | 2 (1, 5) | |
| Hospital stay, days | 9 (7, 13) | 9 (7, 12) | 10 (8, 15) | |
| 30-day mortality, | 36 (4.0%) | 23 (3.5%) | 13 (7.1%) | |
The multivariate logistic regression analysis for 30 days mortality. Variables included in the regression analysis: age, EuroSCORE II, aortic aneurysm, aortic calcification, COPD, coronary heart disease, chronic renal insufficiency, additional CABG, and cardiopulmonary bypass time
| Odds ratio | CI | ||
|---|---|---|---|
| Age > 75 years | 2.799 | 1.184–6.616 | |
| Cardiopulmonary bypass time | 1.022 | 1.013–1.032 | |
| Cross-clamp time | 0.985 | 0.972–0.999 | |
| Postoperative blood transfusion | 4.650 | 1.550–13.952 |